Read My Lips, Allergan CEO Tells M&A-Craving Analysts: Don't Expect a Megamerger From Us

Source: FiercePharma

Thursday, May 11, 2017 | Acquisitions/Mergers , Allergan


Anyone who tuned into Allergan’s Q1 earnings call hoping for signs of big M&A to come likely left disappointed. CEO Brent Saunders, as he has repeatedly over the past year, emphasized Allergan's commitment to smaller, “stepping-stone deals”—but this time, he went a step further in shutting down hopes of a Pfizergan-style megamerger.

Open in New Window

Comments

You must be logged in to leave a comment.